These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 29716795

  • 1. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Neven E, Vervaet B, Brand K, Gottwald-Hostalek U, Opdebeeck B, De Maré A, Verhulst A, Lalau JD, Kamel S, De Broe ME, D'Haese PC.
    Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795
    [Abstract] [Full Text] [Related]

  • 2. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y, Zhang H, Li Y, Li Q, Zuo L.
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [Abstract] [Full Text] [Related]

  • 3. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.
    Williams MJ, Sugatani T, Agapova OA, Fang Y, Gaut JP, Faugere MC, Malluche HH, Hruska KA.
    Kidney Int; 2018 Jan; 93(1):147-158. PubMed ID: 28843411
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.
    de Castro BBA, do Carmo WB, de Albuquerque Suassuna PG, Carminatti M, Brito JB, Dominguez WV, de Oliveira IB, Jorgetti V, Custodio MR, Sanders-Pinheiro H.
    Exp Biol Med (Maywood); 2018 May; 243(9):796-802. PubMed ID: 29763365
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Renoprotective effects of sucroferric oxyhydroxide in a rat model of chronic renal failure.
    Neven E, Corremans R, Vervaet BA, Funk F, Walpen S, Behets GJ, D'Haese PC, Verhulst A.
    Nephrol Dial Transplant; 2020 Oct 01; 35(10):1689-1699. PubMed ID: 33022710
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of tissue-nonspecific alkaline phosphatase protects against medial arterial calcification and improves survival probability in the CKD-MBD mouse model.
    Tani T, Fujiwara M, Orimo H, Shimizu A, Narisawa S, Pinkerton AB, Millán JL, Tsuruoka S.
    J Pathol; 2020 Jan 01; 250(1):30-41. PubMed ID: 31509234
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Newly Developed Rat Model of Chronic Kidney Disease-Mineral Bone Disorder.
    Watanabe K, Fujii H, Goto S, Nakai K, Kono K, Watanabe S, Shinohara M, Nishi S.
    J Atheroscler Thromb; 2018 Feb 01; 25(2):170-177. PubMed ID: 28674323
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.
    Reiss AB, Miyawaki N, Moon J, Kasselman LJ, Voloshyna I, D'Avino R, De Leon J.
    Atherosclerosis; 2018 Nov 01; 278():49-59. PubMed ID: 30253289
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
    Yamada S, Tatsumoto N, Tokumoto M, Noguchi H, Ooboshi H, Kitazono T, Tsuruya K.
    Calcif Tissue Int; 2015 Apr 01; 96(4):347-58. PubMed ID: 25511229
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.